Sennett Marjorie 4

What Happened

• Marjorie Sennett, a director of Cognex Corporation, received a grant of 4,817 restricted stock units (RSUs) on Feb 17, 2026 and, on Feb 18, 2026, exercised/converted 8,324 derivative units into 8,324 shares. Reported prices are $0.00, so no cash purchase was recorded and no sale of shares occurred. These transactions are awards/conversions rather than open-market buys or sales.

Key Details

• Transaction dates and types:
  • 2026-02-17: Grant/award of 4,817 RSUs (Form 4 code A), $0.00.
  • 2026-02-18: Exercise/conversion of derivative (Form 4 code M) resulting in acquisition of 8,324 shares, $0.00.
  • 2026-02-18: Corresponding disposition of the derivative instrument (M) for 8,324 units, $0.00 (this reflects conversion/surrender of the derivative).
• Shares owned after transaction: Not disclosed in the excerpt of the filing.
• Footnotes of note:
  • Each RSU represents a contingent right to receive one share of Cognex common stock (F1).
  • Vesting: certain RSUs vest 100% on the first anniversary of their grant (footnotes reference Feb 18, 2025 and Feb 17, 2026) (F2, F3).
• Filing timeliness: Report filed 2026-02-19 for transactions on Feb 17–18, 2026 — appears timely (Form 4 is generally due within 2 business days).

Context

• These entries reflect awards and conversion/exercise of derivative securities (likely RSU vesting/conversion), not open‑market purchases or sales. Because no cash was paid and no shares were sold, these transactions are typically administrative (vesting/conversion) rather than a signal of buying or selling intent. Sennett is a director (not indicated as a 10% owner), so this is insider director activity rather than control‑owner trading.